Journal of Carcinogenesis & Mutagenesis

Ionizing Radiation and DNA Damage in Cancer Development

Neeha Elizabeth^* Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA
^*Correspondence: Neeha Elizabeth, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA, Email:

Received: 31-Dec-2025, Manuscript No. JCM-26-31154; Editor assigned: 02-Jan-2026, Pre QC No. JCM-26-31154 (PQ) ; Reviewed: 16-Jan-2026, QC No. JCM-26-31154; Revised: 23-Jan-2026, Manuscript No. JCM-26-31154 (R); Published: 30-Jan-2026, DOI: 10.35248/2157-2518.26. 57.001

Description

Ionizing radiation is a powerful physical mutagen that plays a significant role in inducing genetic instability, a hallmark of cancer development. Its high-energy nature allows it to penetrate biological tissues and interact directly with cellular components, particularly DNA. This interaction leads to a range of molecular alterations that can compromise genomic integrity and initiate carcinogenesis. Among the most critical forms of radiationinduced damage are DNA strand breaks, especially double-strand breaks, which are highly deleterious and challenging for the cell to repair accurately [1].

When ionizing radiation passes through a cell, it can ionize atoms within DNA molecules, resulting in direct disruption of the sugar-phosphate backbone. This leads to single-strand and double-strand breaks, as well as base damage. Double-strand breaks are particularly dangerous because they involve simultaneous cleavage of both DNA strands, making repair more complex. If these breaks are not properly repaired, they can result in chromosomal rearrangements such as translocations, inversions, and deletions, all of which are commonly associated with cancer [2].

In addition to direct effects, ionizing radiation also induces indirect damage through the generation of reactive oxygen species via the radiolysis of water. These reactive molecules, including hydroxyl radicals, can interact with DNA bases and cause oxidative damage. Such lesions may lead to mispairing during DNA replication, resulting in mutations that accumulate over time. The combined effects of direct and indirect damage contribute significantly to genomic instability [3].

The cellular response to DNA damage involves activation of complex signaling pathways that regulate cell cycle arrest, DNA repair, or apoptosis. Key repair mechanisms such as homologous recombination and non-homologous end joining are employed to restore DNA integrity. However, these processes are not always precise, particularly non-homologous end joining, which can introduce errors during repair. Such inaccuracies increase the likelihood of mutagenesis and malignant transformation [4-7].

Ionizing radiation is widely used in medical imaging and cancer therapy, making its biological effects highly relevant to human health. In radiotherapy, the goal is to induce lethal DNA damage in tumor cells. However, normal cells in the vicinity are also exposed, which may lead to unintended genetic alterations. Over time, these changes can increase the risk of secondary cancers, highlighting the need for careful dose management and treatment planning.

The extent of radiation-induced DNA damage depends on several factors, including radiation type, dose, and exposure duration. High doses tend to cause extensive damage leading to cell death, while lower doses may allow cells to survive with mutations. This dose-dependent effect is important in understanding both the therapeutic and carcinogenic potential of radiation [8-10].

Cytogenetic analysis has been instrumental in identifying DNA damage caused by ionizing radiation. Techniques such as chromosomal aberration assays and micronucleus tests are commonly used to assess genomic instability. These methods provide valuable insights into the biological impact of radiation and are widely applied in research, clinical diagnostics, and radiation protection.

In conclusion, ionizing radiation is a major contributor to DNA damage and genetic instability, with profound implications for cancer development. Its ability to induce both direct and indirect DNA alterations underscores its significance as a carcinogenic agent. Continued research into its mechanisms of action is essential for improving therapeutic applications, enhancing radiation safety, and reducing long-term health risks.

References

1. Watanabe M. Recent topics and perspectives on esophageal cancer in Japan. JMA J. 2018;1(1):30-9.

   [Crossref] [Google Scholar] [PubMed]

2. Ueoka R, Moss RA, Swarup S, Matsumoto Y, Strauss G, Murakami Y. Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J Am Chem Soc. 1985;107:2185-2186. 

   [Google Scholar]

3. Ueoka R, Matsumoto Y, Moss RA, Swarup S, Sugii A, Harada K, et al. Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J Am Chem Soc. 1988;110:1588-1595.

   [Google Scholar]

4. Ueoka R, Yamada E, Yamashita O, Matsumoto Y, Kato Y. Composition- and temperature-sensitive membranes composed of phosphatidylcholine and Triton X-100 for the remarkably enhanced stereoselective-hydrolysis. Tetrahedron Lett. 1991;32:6597-6600.

   [Crossref] [Google Scholar]

5. Kitamura I, Kochi M, Matsumoto Y, Ueoka R, Kuratsu J, Ushio Y. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: An experimental study. Cancer Res. 1996;56:3986-3992.

   [Google Scholar] [PubMed]

6. Matsumoto Y, Iwamoto Y, Matsushita T, Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int J Cancer. 2005;115(3):377-382.

   [Crossref] [Google Scholar] [PubMed]

7. Nagami H, Nakano K, Ichihara H, Matsumoto Y, Ueoka R. Two methylene groups in phospholipids distinguish between apoptosis and necrosis for tumor cells. Bioorg Med Chem Lett. 2006;16(4):782-785.

   [Crossref] [Google Scholar] [PubMed]

8. Mohty M, Malard F, Alaskar AS, Aijurf M, Arat M, Bader P, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplant. 2023;58:749-754.

   [Crossref] [Google Scholar] [PubMed]

9. Ravaiol F, Colecchia A, Peccatori J, Pagliara D, Grassi A, Barbato F, et al. Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after Hematopoietic Stem Cell Transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial. Bone Marrow Transplant. 2025;60:978-993.

   [Crossref] [Google Scholar] [PubMed]

10. Do Carmo LHK, De Carvalho Freitas MT, Colla RB, Verdan S, Bando TY, Andrade M, et al. Transient and shear-wave elastography in the detection of hepatic sinusoidal obstruction syndrome patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transplant Cell Ther. 2025;4:S2666-6367(25)01407-1.

    [Crossref] [Google Scholar] [PubMed]